The purpose is to compare the efficacy of zanidatamab plus chemotherapy versus trastuzumab plus chemotherapy
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Claire Dees
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Breast)
Women's Health
25-1169
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
